{"id":24205,"date":"2024-02-26T21:06:20","date_gmt":"2024-02-27T03:06:20","guid":{"rendered":"https:\/\/ustower.net\/?p=24205"},"modified":"2024-02-26T21:06:28","modified_gmt":"2024-02-27T03:06:28","slug":"mercks-bridion-faces-generic-threat-from-drugmaker-hikma","status":"publish","type":"post","link":"https:\/\/ustower.net\/?p=24205","title":{"rendered":"Merck&#8217;s Bridion faces generic threat from drugmaker Hikma"},"content":{"rendered":"\n<p class=\"has-medium-font-size\">Feb 26 (Reuters) &#8211; Merck&nbsp;<a target=\"_blank\" href=\"https:\/\/www.reuters.com\/markets\/companies\/MRK.N\" rel=\"noreferrer noopener\">(MRK.N), opens new tab<\/a>&nbsp;has received a letter that Hikma Pharmaceuticals&nbsp;<a target=\"_blank\" href=\"https:\/\/www.reuters.com\/markets\/companies\/HIK.L\" rel=\"noreferrer noopener\">(HIK.L), opens new tab<\/a>&nbsp;US unit has sought a pre-patent expiry approval from the US FDA to sell a generic version of its Bridion injection, the drugmaker said in filing on Monday.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">Merck said, on Feb. 5, it received the letter under the Hatch-Waxman Act, through which a company can seek FDA approval to market a copycat before the expiration of patents related to the brand-name drug.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">Merck&nbsp;<a target=\"_blank\" href=\"https:\/\/www.sec.gov\/ixviewer\/ix.html?doc=\/Archives\/edgar\/data\/0000310158\/000162828024006850\/mrk-20231231.htm\" rel=\"noreferrer noopener\">said, opens new tab<\/a>&nbsp;in the filing that it is currently considering its options.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">Both Merck and Hikma did not immediately respond to Reuters requests for comment.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">Bridion, chemically known as sugammadex, is approved to reverse the effects of muscle relaxants used in surgery. The injection has a patent protection through at least Jan. 2026.<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/mercks-bridion-faces-generic-threat-drugmaker-hikma-2024-02-26\/\">reuters<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Feb 26 (Reuters) &#8211; Merck&nbsp;(MRK.N), opens new tab&nbsp;has received a letter that Hikma Pharmaceuticals&nbsp;(HIK.L), opens new tab&nbsp;US unit has sought a pre-patent expiry approval from the US FDA to sell a generic version of its Bridion injection, the drugmaker said in filing on Monday. Merck said, on Feb. 5, it received the letter under the [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":24206,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5784],"tags":[26862,26863,7964],"class_list":["post-24205","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-bridion-pharmaceuticals","tag-hikma","tag-merck"],"_links":{"self":[{"href":"https:\/\/ustower.net\/index.php?rest_route=\/wp\/v2\/posts\/24205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ustower.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ustower.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ustower.net\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/ustower.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=24205"}],"version-history":[{"count":1,"href":"https:\/\/ustower.net\/index.php?rest_route=\/wp\/v2\/posts\/24205\/revisions"}],"predecessor-version":[{"id":24207,"href":"https:\/\/ustower.net\/index.php?rest_route=\/wp\/v2\/posts\/24205\/revisions\/24207"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ustower.net\/index.php?rest_route=\/wp\/v2\/media\/24206"}],"wp:attachment":[{"href":"https:\/\/ustower.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=24205"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ustower.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=24205"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ustower.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=24205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}